Enhanced suppression of human myeloid leukemic cell lines by combinations of IL-6, LIF, GM-CSF and G-CSF
- PMID: 1689277
- DOI: 10.1002/ijc.2910450224
Enhanced suppression of human myeloid leukemic cell lines by combinations of IL-6, LIF, GM-CSF and G-CSF
Abstract
The interactions of purified recombinant human leukemia inhibitory factor (LIF), interleukin-6 (IL-6), granulocyte colony stimulating factor (G-CSF), and granulocyte-macrophage CSF (GM-CSF) on the clonogenicity of HL60 cells and U937 cells were studied in vitro. IL-6 alone strongly suppressed colony formation by U937 cells with induction of differentiation and loss of clonogenicity. GM-CSF interacted synergistically with IL-6 to further reduce colony number and suppress the growth of clonogenic cells formed by HL60 and U937 cells. LIF synergized with IL-6 to reduce colony number and enhance the suppression of the clonogenic U937 cells. The results suggest that these 4 glycoproteins, acting alone or in combination, may be able to suppress human leukemia cells of appropriate type and be of value in the clinical management of myeloid leukemia.
Similar articles
-
Clonal suppression of HL60 and U937 cells by recombinant human leukemia inhibitory factor in combination with GM-CSF or G-CSF.Leukemia. 1989 Apr;3(4):270-6. Leukemia. 1989. PMID: 2467145
-
Synergistic suppression of the clonogenicity of U937 leukemic cells by combinations of recombinant human interleukin 4 and granulocyte colony-stimulating factor.Exp Hematol. 1992 Nov;20(10):1201-7. Exp Hematol. 1992. PMID: 1385197
-
The induction and inhibition of differentiation in normal and leukaemic cells.Philos Trans R Soc Lond B Biol Sci. 1990 Mar 12;327(1239):99-109. doi: 10.1098/rstb.1990.0046. Philos Trans R Soc Lond B Biol Sci. 1990. PMID: 1690902 Review.
-
The pleiotropic actions of leukemia inhibitory factor.Cancer Cells. 1989 Nov;1(3):77-80. Cancer Cells. 1989. PMID: 2518284 Review.
-
Clonal analysis of the actions of the murine leukemia inhibitory factor on leukemic and normal murine hemopoietic cells.Leukemia. 1988 Apr;2(4):216-21. Leukemia. 1988. PMID: 2452326
Cited by
-
Synergistic suppression: anomalous inhibition of the proliferation of factor-dependent hemopoietic cells by combination of two colony-stimulating factors.Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2819-23. doi: 10.1073/pnas.89.7.2819. Proc Natl Acad Sci U S A. 1992. PMID: 1532659 Free PMC article.
-
The preleukemic state of mice reconstituted with Mixl1-transduced marrow cells.Proc Natl Acad Sci U S A. 2007 Dec 11;104(50):20013-8. doi: 10.1073/pnas.0710339104. Epub 2007 Dec 3. Proc Natl Acad Sci U S A. 2007. PMID: 18056627 Free PMC article.
-
Antitumor effects of recombinant interleukin-6 expressed in eukaryotic cells.Cancer Immunol Immunother. 1993;36(2):101-7. doi: 10.1007/BF01754409. Cancer Immunol Immunother. 1993. PMID: 8425207 Free PMC article.
-
The colony-stimulating factors and cancer.Cancer Immunol Res. 2013 Dec;1(6):351-6. doi: 10.1158/2326-6066.CIR-13-0151. Cancer Immunol Res. 2013. PMID: 24524092 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources